The persistence of the malaria parasite P. falciparum during the proliferation phase in red blood cells of its human host depends on the successive expression of variant molecules on the surface of the infected erythrocytes. This variation is mediated by the differential expression of a polymorphic parasite protein, P. falciparum erythrocyte membrane protein 1 (PfEMP1), which is encoded by 60 var genes. Antigenic variation of PfEMP1 is a major mechanism that the malaria parasite uses to evade attack by host antibodies. It is generally assumed that a better understanding of this mechanism might reveal a new Achilles' heel that could be exploited for developing therapeutics against P. falciparum. A recent paper in Nature suggests that an active var promoter by itself is sufficient to silence endogenous var genes and to ensure monoallelic expression of a single var gene (see Figure 1) .
Since the discovery of the var gene family in 1995 by the Wellems laboratory (Su et al., 1995) , a basic molecular understanding of malaria parasite antigenic variation has been achieved. Early evidence for epigenetic control of antigenic variation came from a study showing that var gene switching occurs in situ from telomeric and central var gene locations without any programmed DNA rearrangements (Scherf et al., 1998) . Furthermore, nuclear runon analyses showed that in situ var gene expression is controlled at the level of transcriptional initiation. Subsequently, data from reporter constructs suggested that var promoter silencing requires an intron located between exons 1 and 2 (Deitsch et al., 2001) .
Although our understanding of P. falciparum epigenetics is still in its infancy, it is increasingly evident that antigenic variation is controlled by a number of different factors. P. falciparum telomeric regions promote the nucleation of silencing factors such as a protein homologous to the Sir2 (silent information regulator 2) protein of the yeast Saccharomyces cerevisiae. Histone acetylation and the P. falciparum homolog of Sir2, PfSir2, mark var gene promoters for monoallelic var gene expression . Moreover, subtelomeric var genes are switched on in PfSir2 mutant parasites, whereas var genes located in central chromosomal regions generally remain silent (Duraisingh et al., 2005) . The remodeling of var promoters by histone modifications is likely to be involved in the silencing of all var genes, whereas silencing by PfSir2 applies to only a subset of telomeric var genes (for review, see ). This is also reflected in the perinuclear location of var genes. In general, subtelomeric var genes are associated with telomeric clusters, whereas var genes in central chromosomal regions apparently are not .
In addition to changes in chromatin at promoters, other types of epigenetic modifications are a prerequisite for var gene activation. For example, the relocation of a telomeric var gene into a transcriptionally competent perinuclear region has been observed (Duraisingh et al., 2005; . Although the nature of this perinuclear transcription zone remains elusive, analysis of serial sections of P. falciparum nuclei by electron microscopy revealed a perinuclear region that is in fact devoid of heterochromatin (S.A. Ralph and A.S., unpublished data). Thus, it appears that var transcription is a consequence of positioning var genes into regions of euchromatin at the periphery of the nucleus.
Despite the variety of epigenetic factors that control central and telomeric var gene activation, it is important to keep in mind that basically all var genes obey the rule of allelic exclusion and must therefore be linked by a common mechanism when it comes to the switching of expression to a single member of this gene family. The genetic control elements that determine mutually exclusive expression remain elusive. In their recent Nature article, Voss et al. (2005) identified a single genetic element of the var gene transcriptional unit that mediates silencing of a transgene (in this case a selectable drug resistance marker gene). Once activated by the drug, the transgene promoter is sufficient to silence endogenous var genes. The most surprising result is that a var promoter driving the selection transgene Immune evasion by the malaria parasite Plasmodium falciparum is mediated by the mutually exclusive expression of a single member of the var family of genes, which encode variant surface antigens. In a recent paper in Nature, Voss et al. (2005) demonstrate that a construct carrying a transcriptionally active var promoter is sufficient to promote allelic exclusion of the parasite's endogenous var gene.
(human dihyrofolate reductase, hDHFR) from an episome is able to infiltrate the var gene allelic exclusion program to silence endogenous var genes. It remains to be seen whether silencing by PfSir2-dependent var promoters (type upsA) is also independent of chromosomal integration. Having the ability to silence the expression of the immunodominant surface molecule encoded by var genes now opens up the possibility of exploring the role of other variant surface molecules in malaria pathology. The work of Voss and colleagues challenges previous work on intron-mediated var promoter silencing (see Figure 1 ; Deitsch et al., 2001; Gannoun-Zaki et al., 2005) . The role that was postulated earlier for the var intron in silencing needs to be reexamined in the light of these new data, which clearly demonstrate that there is no absolute requirement for the intron to silence or activate a var promoter controlling a transgene. Can this new data be reconciled with the previous reports? The major difference in experimental design is that in the Voss et al. (2005) study, the var promoter is forced via drug selection to transcribe a drug resistance marker gene at high rates (see Figure 1) . This is not the case in the transient luciferase assays used by Deitsch and colleagues (2001) , which probably measures a weak var promoter activity in the presence of an active endogenous var gene. Thus, the intron may have the strength to silence a weakly transcribed var promoter. It is reasonable to propose that the intron has a more subtle role in enhancing repression of the var promoter.
The var genes located in central chromosomal regions are found in several clusters. However, when a single member of this cluster is activated, other var genes in the direct vicinity remain silenced. How this is achieved remains enigmatic. The data of Voss et al. (2005) show that the presence of the intron in the episome efficiently reduces the transcription of the second selectable marker gene encoding blasticidin. This suggests that var introns are barriers to transcription.
Obviously, the creation of an intronless endogenous var gene in its chromosomal context should tell us more about the biological role of the var intron.
However, the strict rule that var promoter transcription is mutually exclusive can be overcome experimentally. Synthetic var genes are transcribed from heterologous promoters on episomes without silencing the endogenous var gene (N.K. Viebig, B. Gamain, and A.S., unpublished data) . This further supports the role of the var promoter as the key genetic element that controls allelic exclusion. A recent report, however, demonstrates that two endogenous var promoters can be active at the same time under specific experimental conditions, one being the promoter for the normally expressed var gene and the other the promoter for a second var gene (var2CSA) that is normally silent. The integration of an active DHFR expression cassette approximately 4 kb downstream from the normally silent var2CSA promoter leads to truncated var2CSA transcripts (Viebig et al., 2005) . How the allelic exclusion control system is defeated by this event remains unclear. This result, however, demonstrates the fragility of the parasite's allelic exclusion system, and it may be wise to interpret data obtained from transgene var transcription experiments with caution.
What emerges from the Voss et al. (2005) study is that a single genetic element located upstream of var genes apparently contains all of the information necessary to activate var genes in a mutually exclusive manner. This is a big step forward in trying to understand a puzzling biological concept that is a Holy Grail in many research areas, including the field of molecular parasitology (Borst, 2002) . We hope that other enigmatic epigenetic mechanisms, such as those that control variable rates of var gene switching (Horrocks et al., 2004) will not remain an eternal mystery. The migration of hematopoietic stem cells (HSCs) is evident in several circumstances. During development, HSCs seed new sites of hematopoiesis, and under physiological conditions in adult life, HSCs continuously move between the bone marrow and the bloodstream. Also, a massive efflux of HSCs, a process called mobilization, occurs following treatment with cytotoxic drugs or cytokines such as granulocyte colony-stimulating factor (G-CSF), whereas following intravenous injection into transplant recipients, HSCs migrate to and engraft in the bone marrow. Although the mobilization and transplantation of HSCs is widely used in modern clinical medicine, the precise mechanisms by which HSCs exit their niche or reengage their niche after transplantation are still being unraveled. Katayama et al. (2006) now report that the sympathetic nervous system is a key and previously unrecognized participant in HSC mobilization.
As a result of more than four decades of studies using mostly rodent models and an equally long clinical tradition of bone-marrow transplantation regimens, HSCs are the best characterized population of stem cells. However, the field has been held back by an imprecise understanding of the microenvironment, or niche, in which the HSCs reside. This, for obvious reasons, has hampered detailed investigation of the mobilization and engraftment process. Studies of the HSC microenvironment have been limited by the fact that the most liquid of tissues, bone marrow, is encased by the most solid. By labeling stem cells and reinfusing them, it has been shown that HSCs reside in close proximity to the endosteal bone surface, and the assumption has been made that maturing cells become redistributed toward the central marrow region. Recently, two genetic studies identified osteoblasts as crucial cellular components of the HSC microenvinervous Activity in a stem Cell niche Jonas Larsson 1,2,3 and David Scadden 1,2, *
